Vascular Dilation, Tachycardia, and Increased Inotropy Occur Sequentially with Increasing Epinephrine Dose Rate, Plasma and Myocardial Concentrations, and cAMP

Heart Lung and Circulation

Volumn 24, Issue 9, 2015, Pages 912-918

  Maslov, Mikhail Y ^a   Wei, Abraham E ^a   Pezone, Matthew J ^a   Edelman, Elazer R ^b   Lovich, Mark A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

CAMP; Contractility; Epinephrine; Heart rate; Myocardial tissue; Vascular tone

Indexed keywords

ADRENALIN; CYCLIC AMP; CARDIOTONIC AGENT; EPINEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; EC50; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART RATE; INOTROPISM; LUSITROPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; VASODILATATION; ANIMAL; BLOOD; CARDIAC MUSCLE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; HEART CONTRACTION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CARDIOTONIC AGENTS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HEART RATE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; TACHYCARDIA; VASODILATION;

EID: 84940792955     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.02.012     Document Type: Article

References (32)

1. Salak N., Pajk W., Knotzer H., Hofstötter H., Schwarz B., Mayr A., et al. Effects of epinephrine on intestinal oxygen supply and mucosal tissue oxygen tension in pigs. Crit Care Med. 2001, 29:367-373.
2. Schwarte L.A., Schwartges I., Schober P., Scheeren T.W., Fournell A., Picker O. Sevoflurane and propofol anaesthesia differentially modulate the effects of epinephrine and norepinephrine on microcirculatory gastric mucosal oxygenation. Br J Anaesth. 2010, 105:421-428.
3. Spencer M.P., Denison A.B., Green H.D. The Direct Renal Vascular Effects of Epinephrine and Norepinephrine before and after Adrenergic Blockade. Circ Res. 1954, 2:537-540.
4. Chilian W.M., Layne S.M., Eastham C.L., Marcus M.L. Effects of epinephrine on coronary microvascular diameters. Circ Res. 1987, 61(5 Pt 2):1147-1153.
5. Latorre G., Cardenas V., Lopez O. Mechanism of the effect of constant infusion of epinephrine on blood pressure, heart rate and arterial hematocrit in normal and sympathectomized-splanchnicectomized dogs. Arch Int Physiol Biochim. 1960, 68:785-792.
6. Furnival C.M., Linden R.J., Snow H.M. The inotropic and chronotropic effects of catecholamines on the dog heart. J Physiol. 1971, 214(1):15-28.
7. Stratton J.R., Pfeifer M.A., Ritchie J.L., Halter J.B. Hemodynamic effects of epinephrine: concentration-effect study in humans. J Appl Physiol. 1985, 58:1199-1206.
8. Tarnow J., Müller R.K. Cardiovascular effect of low-dose epinephrine infusions in relation to the extent of preoperative beta-adrenoceptor blockade. Anesthesiology. 1991, 74:1035-1043.
9. Bersten A.D., Rutten A.J., Summersides G., Ilsley A.H. Epinephrine infusion in sheep: systemic and renal hemodynamic effects. Crit Care Med. 1994, 22:994-1001.
10. Nachar R.A., Booth E.A., Friedlich P., Borzage M., Soleymani S., Wider M.D., et al. Dose-dependent hemodynamic and metabolic effects of vasoactive medications in normotensive, anesthetized neonatal piglets. Pediatr Res. 2011, 70:473-479.
11. Goodman A., Rall T., Neis A., Taylot P. Goodman and Gilman's The Pharmacological Basis of Therapeutics 1990, 187. Pergamon Press, New York. 8th ed.
12. 1 Activation of Heart cAMP-dependent Protein Kinase: Apparent Dissociation of Protein Kinase Activation from Increases in Phosphorylase Activity and Contractile Force. Mol Pharmacol. 1979, 15(2):235-245.
13. Kaumann A.J. Adrenaline and noradrenaline increase force of human ventricle through both beta1 and beta2-adrenoreceptors. Biomed Biochim Acta. 1987, 46(8-9):S411-S416.
14. Tanigawa T., Yano M., Kohno M., Yamamoto T., Hisaoka T., Ono K., et al. Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure. Am J Physiol Heart Circ Physiology. 2000, 278:H313-H320.
15. Pacher P., Nagayama T., Mukhopadhyay P., Bátkai S., Kass D.A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008, 3:1422-1434.
16. Horstick G., Lauterbach M., Kempf T., Ossendorf M., Kopacz L., Heimann A., et al. Plasma protein loss during surgery: beneficial effects of albumin substitution. Shock. 2001, 16:9-14.
17. Westermann J., Hubl W., Kaiser N., Salewski L. Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method. Clin Lab. 2002, 48:61-71.
18. Kakarla S.K., Fannin J.C., Keshavarzian S., Katta A., Paturi S., Nalabotu S.K., et al. Chronic acetaminophen attenuates age-associated increases in cardiac ROS and apoptosis in the Fischer Brown Norway rat. Basic Res Cardiol. 2010, 105:535-544.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72:248-254.
20. Günnicker M., Brinkmann M., Donovan T.J., Freund U., Schieffer M., Reidemeister J.C. The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade. Thorac Cardiovasc Surg. 1995, 43(3):153-160.
21. Tempe D.K., Virmani S. Pharmacologic support of circulation in patients undergoing cardiac surgery. J Indian Med Assoc. 1999, 97(10):411-418.
22. Annane D., Vignon P., Renault A., Bollaert P.E., Charpentier C., Martin C., et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007, 370:676-684.
23. Kass D.A., Maughan W.L. From 'Emax' to pressure-volume relations: a broader view. Circulation. 1988, 77(6):1203-1212.
24. Sato T., Shishido T., Kawada T., Miyano H., Miyashita H., Inagaki M., et al. ESPVR of in situ rat left ventricle shows contractility-dependent curvilinearity. Am J Physiol. 1998, 274(5 Pt 2):H1429-H1434.
25. Champion H.C., Georgakopoulos D., Haldar S., Wang L., Wang Y., Kass D.A. Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology. Circulation. 2003, 108(22):2790-2797.
26. Dobson J.G. Protein kinase regulation of cardiac phosphorylase activity and contreactility. Am J Physiol. 1978, 234(May (5)):H638-H645.
27. Labrosse E.H., Axelrod J., Kety S.S. O-Methylation, the principal route of metabolism of epinephrine in man. Science. 1958, 128:593-604.
28. Gennser G., Rosengren E., von Studnitz W. Distribution of noradrenaline and of monoamine oxidase and catechol-O-methyltransferase activity in human heart. Experientia. 1973, 29:20-22.
29. Devic E., Xiang Y., Gould D., Kobilka B. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol. 2001, 60:577-583.
30. Weitl N., Seifert R.J. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine. Pharmacol Exp Ther. 2008, 327:760-769.
31. Beau S.L., Hand D.E., Schuessler R.B., Bromberg B.I., Kwon B., Boineau J.P., et al. Relative densities of muscarinic cholinergic and beta-adrenergic receptors in the canine sinoatrial node and their relation to sites of pacemaker activity. Circ Res. 1995, 77:957-963.
32. Rodefeld M.D., Beau S.L., Schuessler R.B., Boineau J.P., Saffitz J.E. Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density. J Cardiovasc Electrophysiol. 1996, 7(11):1039-1049.